The field of "Biopharmaceuticals Engineering" in our lab is dedicated to advancing the development of biocompatible pharmaceuticals through innovative protein engineering. 

Our research aims to refine separation and purification processes to achieve high levels of purity and maximize productivity, which is critical for the effective manufacture of biopharmaceuticals. Furthermore, we focus on creating rapid contaminant analysis technologies to ensure the highest standards of safety and quality control throughout the production process. 

Nucleic acid engineering is a branch of genetic engineering that involves the manipulation of nucleic acids, such as DNA and RNA, for various purposes. This field aims to design and create synthetic DNA and RNA molecules with specific sequences, functions, and properties.

Nucleic acid engineering involves the use of various techniques, including gene synthesis, DNA sequencing, PCR (polymerase chain reaction), and genetic engineering. This field has numerous applications in areas such as biotechnology, medicine, and nanotechnology.

Point-of-care testing (POCT) is a medical testing method that allows for rapid diagnostic tests to be performed near the patient, without the need for sending samples to a centralized laboratory. POCT is typically performed by non-laboratory personnel, such as doctors, nurses, or trained technicians, and provides results within minutes to hours.

POCT can be performed using various technologies, such as lateral flow assays, biosensors, and microfluidics. It is used to diagnose a wide range of conditions, including infectious diseases, cardiac diseases, and diabetes.

An electrochemical biosensor is a type of biosensor that uses an electrochemical signal to detect and quantify a target analyte. Biosensors are analytical devices that combine a biological sensing element with a physicochemical transducer to convert a biological signal into a measurable signal.

Electrochemical biosensors typically consist of three components: a biological recognition element (such as an enzyme or an antibody), a transducer (such as an electrode), and a signal processing unit. When the biological recognition element interacts with the target analyte, it produces a biochemical reaction that generates an electrical signal that is detected and quantified by the transducer.